One of the most promising compounds was Trabedersen, an anti-sense oligonucleotide against TGF-β2 mRNA that was shown to inhibit tumor proliferation and enhance anti-tumor immunity in vitro (228). This evidence concerns the gene TGFB2 and neoplasm.